CLINICAL_TRIALS
trial_result
· 2025-10-21
Clinical Trial Update: A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme [Phase 4]
Summary
Phase 4 prospective study evaluating the safety and tolerability of a shorter infusion of Fabrazyme for Fabry disease; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Fabry's Disease | Phase 4 | Status: COMPLETED | Results posted: 2025-10-21